diabetes

(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug...

(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found.

(Newser) - The battle to keep pounds off may start with a baby bottle, say a team of British scientists who found that feeding large doses of the appetite-controlling hormone leptin to baby rats led to svelte adult rats. If those results translate to humans, a baby formula that chemically alters metabolism...

(Newser) - The country's largest health insurer says it will pay up for good health--offering bonuses to employees who boost patients' use of preventive medical services. WellPoint Inc.'s plan is intended to encourage participation in programs like diabetes management, which helps patients handle their medical needs before they end up in...